Gennex Laboratories Other Announcement
Gennex Laboratories Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Gennex Laboratories Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Gennex Laboratories Ltd filed its quarterly shareholding pattern. The company has applied for trading approval for 1.55 crore shares issued via warrant conversion.
Gennex Laboratories submitted its Annual Secretarial Compliance Report for the financial year 2025-26. The report confirms adherence to statutory regulations and outlines historical compliance actions taken.